Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
BMC Immunology|June 19, 2021
Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral bloodJihane Boustani, Elodie Lauret Marie Joseph, Etienne Martin, et al.
Cancer Treatment Reviews|September 21, 2023
Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU)Loic Ah-Thiane, Paul Sargos, Olivier Chapet, et al.
The Lancet. Oncology|November 7, 2025
Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trialStefano Kim, Jihane Boustani, Soledad Iseas, et al.
Lancet (London, England)|November 23, 2024
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial designAlberto Bossi, Stéphanie Foulon, Xavier Maldonado, et al.
Frontiers in Oncology|September 19, 2022
Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinomaStefano Kim, Jihane Boustani, Dewi Vernerey, et al.
Oncoimmunology|February 27, 2026
Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancerBenoît Lecoester, Yaoyao Xie, Xushan Sun, et al.
Acta Oncologica (Stockholm, Sweden)|August 31, 2017
Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) InvestigatorsJihane Boustani, Aurélie Bertaut, Matthew D Galsky, et al.
Journal for Immunotherapy of Cancer|July 7, 2021
Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapyElodie Lauret Marie Joseph, Amos Kirilovsky, Benoît Lecoester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2021
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk DiseaseMichel Bolla, Anouk Neven, Philippe Maingon, et al.
European Urology Oncology|January 23, 2026
Oncological Outcomes of Trimodal Therapy in Primary Versus Secondary Muscle-invasive Bladder Cancer: A Multicenter Retrospective StudyGarvey Mezepo, Zine-Eddine Khene, Jihane Boustani, et al.
Pageof 3